VJHemOnc is committed to improving our service to you

Share this video  

VJHemOnc is committed to improving our service to you

IMS 2022 | The curative potential of CAR-T therapy in multiple myeloma

Yi Lin, MD, PhD, Mayo Clinic, Rochester, MN, discusses the curative potential of CAR-T therapy in multiple myeloma, commenting on the use of maintenance therapy and the possibility of combining CAR-T therapy with immunomodulatory drugs. This interview took place at the 19th International Myeloma Society Meeting (IMS) held in Los Angeles, CA.

These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.

Sign-up for our Newsletter!

Keep up to date with all the latest news with our monthly newsletter